Tissue-Engineered “Metastases”: Treatment of Hepatic Colon Tumors with a Dual Action Autotaxin Inhibitor-Lysophosphatidic Acid Receptor Antagonist . Journal of Cancer Research Updates, [S. l.], v. 1, n. 1, p. 69–77, 2021. DOI: 10.6000/1929-2279.2012.01.01.11. Disponível em: https://neoplasiaresearch.com/index.php/jcru/article/view/618. Acesso em: 14 jan. 2026.